Liquidités Changement Date
AstraZeneca USD 4.89B 2.67B 2026-06
Genmab DKK 1.5B 18M 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Lakefront Biotherapeutics EUR 135.95M 69.15M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
UCB EUR 1.57B 1.14B 2024-12